KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Short-Term Debt repayments (2016 - 2021)

Historic Short-Term Debt repayments for Omega Healthcare Investors (OHI) over the last 6 years, with Q1 2021 value amounting to $1.2 billion.

  • Omega Healthcare Investors' Short-Term Debt repayments rose 34266.54% to $1.2 billion in Q1 2021 from the same period last year, while for Mar 2021 it was $2.1 billion, marking a year-over-year increase of 753.1%. This contributed to the annual value of $1.2 billion for FY2020, which is 3975.05% down from last year.
  • As of Q1 2021, Omega Healthcare Investors' Short-Term Debt repayments stood at $1.2 billion, which was up 34266.54% from $300.0 million recorded in Q4 2020.
  • Over the past 5 years, Omega Healthcare Investors' Short-Term Debt repayments peaked at $1.2 billion during Q1 2021, and registered a low of $215.0 million during Q1 2017.
  • Over the past 5 years, Omega Healthcare Investors' median Short-Term Debt repayments value was $335.0 million (recorded in 2018), while the average stood at $423.9 million.
  • Its Short-Term Debt repayments has fluctuated over the past 5 years, first plummeted by 6784.7% in 2020, then soared by 34266.54% in 2021.
  • Over the past 5 years, Omega Healthcare Investors' Short-Term Debt repayments (Quarter) stood at $275.0 million in 2017, then increased by 21.82% to $335.0 million in 2018, then soared by 47.76% to $495.0 million in 2019, then plummeted by 39.39% to $300.0 million in 2020, then surged by 292.5% to $1.2 billion in 2021.
  • Its last three reported values are $1.2 billion in Q1 2021, $300.0 million for Q4 2020, and $227.0 million during Q3 2020.